Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Instagram Outage Disrupts Thousands of U.S. Users 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
TEANECK, N.J., Jan. 02, 2018 -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review its second quarter financial results. Phibro expects to issue a news release containing quarterly results after the market closes on Monday, February 5, 2018.
| Details for the webcast and conference call: | |||
| Date: | Tuesday, February 6, 2018 | ||
| Time: | 9:00 AM Eastern Time | ||
| Location: | http://investors.pahc.com | ||
| U.S. Toll-Free: | +1 (877) 853-5634 | ||
| International Toll: | +1 (315) 625-6893 | ||
| Conference ID: | 69672295 | ||
Note: In order to join this conference call, participants will be required to provide the Conference ID number.
Archive: A replay of the webcast and conference call will be available on Phibro’s website.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $764 million for the fiscal year ended June 30, 2017. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact:
Richard Johnson
Phibro Animal Health Corporation
Chief Financial Officer
+1-201-329-7300
[email protected]
